Skip to content
Dimethicone
Dimethicone is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
hereditary congenital and neonatal diseases and abnormalitiesD009358
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
medline remedy phytoplex skin repairOTC monograph final2022-12-15
regular strength antacid and antigasOTC monograph final2023-06-13
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
skin abnormalitiesHP_0000951D012868Q82.9
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P03: Ectoparasiticides, incl. scabicides, insecticides and repellents
— P03A: Ectoparasiticides, incl. scabicides
— P03AX: Other ectoparasiticides, incl. scabicides in atc
— P03AX05: Dimeticone
HCPCS
No data
Clinical
Clinical Trials
29 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9———123
Coronary artery diseaseD003324I25.1———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SinusitisD012852EFO_0007486J32——1—12
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PsoriasisD011565EFO_0000676L40—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Actinic keratosisD055623L57.01————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MyopiaD009216H52.1————33
Stress urinary incontinenceD014550HP_0010992————22
Healthy volunteers/patients—————11
Diet therapyD004035————11
Metabolic syndromeD024821EFO_0000195E88.81————11
HypersensitivityD006967EFO_0003785T78.40————11
PresbyopiaD011305H52.4————11
PediculusD010374————11
Incisional herniaD000069290HP_0004872K43.2————11
Nasal septal perforationD061270EFO_1001813J34.89————11
Show 12 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIMETHICONE
INNdimeticone
Description
Polydimethylsiloxane (PDMS), also known as dimethylpolysiloxane or dimethicone, is a silicone polymer with a wide variety of uses, from cosmetics to industrial lubrication.
Classification
Unknown
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL2108200
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID92RU3N3Y1O (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 935 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
5,573 adverse events reported
View more details